Läkemedelsverket — Swedish Medical Products Agency
Läkemedelsverket · Sweden · europe
Sweden's medical products agency — regulates leeches via the EU MDR and Patientsäkerhetslagen, with reimbursement limited to inpatient reconstructive indications under regional landsting protocols.
Regulatory Profile
- Agency type
- national regulator
- Region
- europe
- Country
- Sweden
- Leech status
- medical device cleared
- Last ASH review
- 2026-05-25
Relevant Regulation Codes
- Lag (2021:600) om medicintekniska produkter
- Patientsäkerhetslagen (2010:659)
- Förordning (EU) 2017/745 (MDR) — direct effect
Prescriber Requirements
- Legitimerad läkare (registered physician) prescription required
- Sjuksköterska (RN) application under physician's order; specialist sjuksköterska (e.g., wound-care) within scope
- Naturmedicinska practitioners are unregulated — application of leeches outside healthcare-system protocols falls under Hälso- och sjukvårdslagen restrictions on treating minors and certain conditions
Supply Chain & GMP
MDR-aligned manufacturer registration. Swedish-language labelling and IFU for end users. Cold chain 4–10 °C.
Import/Export Rules
Intra-EU free movement. Third-country imports via Tullverket plus Jordbruksverket (Board of Agriculture) for live invertebrate / CITES.
Reimbursement Context
Regional councils (regioner) cover leech therapy in inpatient flap-salvage settings; no outpatient reimbursement category exists. Private payment expected outside hospitals.
Key Regulatory Documents
ASH Editorial Notes
Karolinska University Hospital plastic-surgery service uses leeches in venous-congestion salvage protocols imported from Biopharm UK; clinical adoption modest by EU standards.
Related Jurisdictions
EMA — European Union
Centralised EU authority for medicinal products — leeches sit on the border between MDR-regulated device and HMPC traditional herbal medicine framework.
European Commission — European Union
EU executive body responsible for the Medical Device Regulation (MDR) — the legal instrument that frames how Member States CE-mark leech products.
MHRA — United Kingdom
Post-Brexit UK regulator — accepts EU CE marks during transition, with UKCA marking now phased in for Great Britain (Northern Ireland follows EU MDR via Windsor Framework).
BfArM — Germany
Germany classifies medicinal leeches as a finished medicinal product (Fertigarzneimittel) — uniquely strict among EU Member States and requires marketing authorisation via BfArM.